Trevi Therapeutics Inc.

Trevi Therapeutics Inc. focuses its clinical research activity on idiopathic pulmonary fibrosis with a particular interest in the burden of chronic cough associated with the disease. The sponsor’s trial activity is centered on respiratory symptoms that affect daily functioning and disease experience in pulmonary fibrosis.

• Respiratory symptom management
• Cough frequency assessment
• Fibrotic lung disease

Its research in this area reflects a therapeutic emphasis on symptom relief in interstitial lung disease, especially where persistent cough is a major clinical concern.